INBX Stock Analysis: Buy, Sell, or Hold?
INBX - Inhibrx Biosciences, Inc. Common Stock
$108.33
-7.83 (-6.74%)
▼
5d:
-19.37%
30d:
+30.35%
90d:
+42.92%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Smart Money Accumulation
INBX is down 16.8% this week, but smart money is accumulating calls. Top strike: $80 2026-06-18 with 201 OI. Call ratio: 81% View Scanner →
Strength: 10.0/10
Get Alerted When INBX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called INBX this week
33% bullish • 2 bearish
33% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INBX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: INBX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: INBX is currently trading at $108.33, which is considered extended relative to its 30-day fair value range of $76.07 to $130.52.
Technical Outlook: Technically, INBX is in a uptrend. Immediate support is located at $99.20, while resistance sits at $150.98. Short-term momentum is weak, with the stock down 6.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $265.00 (+128.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INBX is in a uptrend. Immediate support is located at $99.20, while resistance sits at $150.98. Short-term momentum is weak, with the stock down 6.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $265.00 (+128.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$76.07 -
$130.52
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.8%
Protect Your Profits
Holding INBX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.7%)
- BULLISH: Trading 128.1% below Wall St target ($265.00)
- CAUTION: 5-day price weakness (-19.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$76.07 -
$130.52
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$99.20
Resistance Level
$150.98
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-41.63
Wall Street Target
$265.00
(+128.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: May 15, 2026 9:55 AM ET
Data refreshes hourly during market hours. Next update: 10:55 AM
Data refreshes hourly during market hours. Next update: 10:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 54 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$23 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$208 | 49 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 63 BUY |
Advanced INBX Option Strategies
Professional options setups generated by AI based on today's INBX price and gamma walls.
